These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 31652984)

  • 1. Principal Criteria for Evaluating the Quality, Safety and Efficacy of hMSC-Based Products in Clinical Practice: Current Approaches and Challenges.
    Guadix JA; López-Beas J; Clares B; Soriano-Ruiz JL; Zugaza JL; Gálvez-Martín P
    Pharmaceutics; 2019 Oct; 11(11):. PubMed ID: 31652984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of international regulatory frameworks for mesenchymal stromal cell-based medicinal products: From laboratory to patient.
    López-Beas J; Guadix JA; Clares B; Soriano-Ruiz JL; Zugaza JL; Gálvez-Martín P
    Med Res Rev; 2020 Jul; 40(4):1315-1334. PubMed ID: 32017179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion, harvest and cryopreservation of human mesenchymal stem cells in a serum-free microcarrier process.
    Heathman TR; Glyn VA; Picken A; Rafiq QA; Coopman K; Nienow AW; Kara B; Hewitt CJ
    Biotechnol Bioeng; 2015 Aug; 112(8):1696-707. PubMed ID: 25727395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceleration of Translational Mesenchymal Stromal Cell Therapy Through Consistent Quality GMP Manufacturing.
    Jayaraman P; Lim R; Ng J; Vemuri MC
    Front Cell Dev Biol; 2021; 9():648472. PubMed ID: 33928083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manufacturing human mesenchymal stem cells at clinical scale: process and regulatory challenges.
    Jossen V; van den Bos C; Eibl R; Eibl D
    Appl Microbiol Biotechnol; 2018 May; 102(9):3981-3994. PubMed ID: 29564526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peak MSC-Are We There Yet?
    Olsen TR; Ng KS; Lock LT; Ahsan T; Rowley JA
    Front Med (Lausanne); 2018; 5():178. PubMed ID: 29977893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism in Human Mesenchymal Stromal Cells: A Missing Link Between hMSC Biomanufacturing and Therapy?
    Yuan X; Logan TM; Ma T
    Front Immunol; 2019; 10():977. PubMed ID: 31139179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining human mesenchymal stem cell efficacy in vivo.
    Bonfield TL; Nolan Koloze MT; Lennon DP; Caplan AI
    J Inflamm (Lond); 2010 Oct; 7():51. PubMed ID: 20974000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty.
    Golpanian S; DiFede DL; Pujol MV; Lowery MH; Levis-Dusseau S; Goldstein BJ; Schulman IH; Longsomboon B; Wolf A; Khan A; Heldman AW; Goldschmidt-Clermont PJ; Hare JM
    Oncotarget; 2016 Mar; 7(11):11899-912. PubMed ID: 26933813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Throughput On-Chip Human Mesenchymal Stromal Cell Potency Prediction.
    Schneider RS; Vela AC; Williams EK; Martin KE; Lam WA; García AJ
    Adv Healthc Mater; 2022 Jan; 11(2):e2101995. PubMed ID: 34725948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production via good manufacturing practice of exofucosylated human mesenchymal stromal cells for clinical applications.
    López-Lucas MD; Pachón-Peña G; García-Hernández AM; Parrado A; Sánchez-Salinas D; García-Bernal D; Algueró MDC; Martinez FI; Blanquer M; Cabañas-Perianes V; Molina-Molina M; Asín-Aguilar C; Moraleda JM; Sackstein R
    Cytotherapy; 2018 Sep; 20(9):1110-1123. PubMed ID: 30170815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial.
    Hare JM; DiFede DL; Rieger AC; Florea V; Landin AM; El-Khorazaty J; Khan A; Mushtaq M; Lowery MH; Byrnes JJ; Hendel RC; Cohen MG; Alfonso CE; Valasaki K; Pujol MV; Golpanian S; Ghersin E; Fishman JE; Pattany P; Gomes SA; Delgado C; Miki R; Abuzeid F; Vidro-Casiano M; Premer C; Medina A; Porras V; Hatzistergos KE; Anderson E; Mendizabal A; Mitrani R; Heldman AW
    J Am Coll Cardiol; 2017 Feb; 69(5):526-537. PubMed ID: 27856208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Chapter 3: Porcine islet product manufacturing and release testing criteria.
    Rayat GR; Gazda LS; Hawthorne WJ; Hering BJ; Hosking P; Matsumoto S; Rajotte RV
    Xenotransplantation; 2016; 23(1):38-45. PubMed ID: 26923763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparan Sulfate Proteoglycans as Drivers of Neural Progenitors Derived From Human Mesenchymal Stem Cells.
    Okolicsanyi RK; Oikari LE; Yu C; Griffiths LR; Haupt LM
    Front Mol Neurosci; 2018; 11():134. PubMed ID: 29740281
    [No Abstract]   [Full Text] [Related]  

  • 15. Good Manufacturing Practice (GMP) Compliance for Phage Therapy Medicinal Products.
    Bretaudeau L; Tremblais K; Aubrit F; Meichenin M; Arnaud I
    Front Microbiol; 2020; 11():1161. PubMed ID: 32582101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Priming hMSCs with a putative anti-cancer compound, myrtucommulone-a: a way to harness hMSC cytokine expression via modulating PI3K/Akt pathway?
    Iskender B; Izgi K; Sakalar C; Canatan H
    Tumour Biol; 2016 Feb; 37(2):1967-81. PubMed ID: 26334623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymatic detachment of therapeutic mesenchymal stromal cells grown on glass carriers in a bioreactor.
    Salzig D; Schmiermund A; P Grace P; Elseberg C; Weber C; Czermak P
    Open Biomed Eng J; 2013; 7():147-58. PubMed ID: 24478807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new nonenzymatic method and device to obtain a fat tissue derivative highly enriched in pericyte-like elements by mild mechanical forces from human lipoaspirates.
    Bianchi F; Maioli M; Leonardi E; Olivi E; Pasquinelli G; Valente S; Mendez AJ; Ricordi C; Raffaini M; Tremolada C; Ventura C
    Cell Transplant; 2013; 22(11):2063-77. PubMed ID: 23051701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic efficacy of human mesenchymal stromal cells in the repair of established ventilator-induced lung injury in the rat.
    Hayes M; Masterson C; Devaney J; Barry F; Elliman S; O'Brien T; O'Toole D; Curley GF; Laffey JG
    Anesthesiology; 2015 Feb; 122(2):363-73. PubMed ID: 25490744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intervertebral disc response to stem cell treatment is conditioned by disc state and cell carrier: An
    Peroglio M; Douma LS; Caprez TS; Janki M; Benneker LM; Alini M; Grad S
    J Orthop Translat; 2017 Apr; 9():43-51. PubMed ID: 29662798
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.